03.03.22 -- 6 Tips To Ensure Your NDA/BLA Is Ready For FDA Review
03/03/22 Pharmaceutical Online Newsletter
Stay updated with breaking news from Anthony Newcombe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
03/03/22 Pharmaceutical Online Newsletter
During the drug discovery journey, technology transfer is an intrinsic part of the successful development, manufacturing, and commercialization of a...
06/10/21 Pharmaceutical Online Newsletter
Novel gene therapy company VectorY was announced by Merck as the European winner of its 2021 Advance Biotech Grant Program. Click to read more...
Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies Targeting muscular and neurodegenerative disorders Amsterdam-based company seeded by Forbion Co-founded by highly experienced gene therapy technology and manufacturing team VectorY, a fully integrated gene therapy company focused on the development of innovative vectorized antibodies for muscular and neurodegenerative disorders, today announces its official launch. The Company has been operational since October 2020 and has established its laboratories and offices at the Amsterdam Science Park in The Ne...